An Herbal Tea Cured Her Insomnia When Even Meds Couldn't
I can't go on like this, Jamie groaned after hours of tossing and turning. As a night shift RN at a bustling trauma center, she needed to be alert and energetic for her patients, not tired and drained.
After suffering from insomnia for two decades, Jamie was losing hope as she constantly fought to fall and stay asleep, especially in the summer. Jamie learned from researching online that sleep problems spike in warmer temperatures due to impaired thermoregulation and circadian rhythm. Over the years, her doctor prescribed Xanax to calm her anxiety and racing mind and trazodone (a heavy-duty sedative), but they did little to quiet her mind and help her drift off. She also tried over-the-counter Benadryl, which failed to help.
The medication's side effects and lack of sleep left her groggy and foggy-headed, and she never felt fully rested. Over time, the chronic sleep deprivation negatively impacted her quality of life and interfered with her daily activities and responsibilities.
As a busy single mom, Jamie was reluctant to try more heavy prescription medications that only made her feel worse. What am I going to do? she despaired. Then, in 2024, miserable and nearly losing hope, Jamie noticed a local herbalist she followed on Instagram, Michelle McAninch, founder of Tamarac Garden Family Farm, posting about a new organic sleep tea she created. Curious, Jamie reached out to Michelle to learn more.
Michelle's Sweet Dreams Tea is a synergetic blend of five of the most effective herbs for insomnia designed to ease tension, calm the racing mind and promote sound and restful sleep—minus the adverse side effects. Michelle explained that herbs are like people; they're good on their own and even better together, and that was her inspiration for Sweet Dreams Tea for better sleep.
Hops (used as a nonalcoholic flavoring in beer) and catnip both have a sedative effect and boost GABA, the brain's calming neurotransmitters, much like prescription anti-anxiety meds. They help ease stress and promote relaxation. The floral flavors of rose petals and the sweetness of lemon balm and chamomile are rich in antioxidant and anti-inflammatory flavonoids and polyphenols that are beneficial for easing anxiety-related insomnia and emotional overload, nixing mental chatter, calming emotions and relaxing the body and mind.
With nothing to lose, Jamie started drinking the tea the next day after a grueling night shift to see if it would help her sleep. She steeped the tea bag in boiling water for 15 minutes, then removed it and put it in the fridge to cool down, allowing her to get two uses from each bag. When she wanted another cup, she simply set the used tea bag out for about 10 minutes before steeping again. Jamie enjoyed the mild herbal taste and added a teaspoon of honey for extra sweetness.
After her first use, she immediately noticed the tea took the edge off and helped her relax and ease into uninterrupted sleep. Hopeful, she continued to drink the tea, and by day three, she'd drift off within the hour and stay asleep. Jamie marveled at how soundly she slept and woke up feeling rested and refreshed—not groggy.
Today, Jamie still drinks the tea daily for better sleep. 'I get amazing, restful sleep and feel so much better,' she says. She's energetic and no longer drags through her days. Her mind is clear, focused and finally calm. Her insomnia is finally erased, and Jamie is grateful for a natural remedy. 'This tea has changed my sleep and life,' she beams. 'I feel amazing!'
Want to read about more ways to get better sleep? Keep scrolling!
The Melatonin-Free Secret to Better Sleep (and a Better You)
Red Light Therapy for Insomnia: One Woman's Journey to Relief
Scientists Reveal Their 5 Favorite Ways to Get a Better Night's Sleep This Spring
This content is not a substitute for professional medical advice or diagnosis. Always consult your physician before pursuing any treatment plan.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Enanta Pharmaceuticals to Participate in Baird's Biotech Discovery Series
WATERTOWN, Mass., July 15, 2025--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today announced that members of management will participate in a virtual fireside chat on Tuesday, July 22 at 1:30 p.m. ET as part of Baird's Biotech Discovery Series. A live webcast of the event will be accessible by visiting the "Events and Presentations" section on the "Investors" page of Enanta's website at A replay of the webcast will be available following the event and will be archived for at least 30 days. About Enanta Pharmaceuticals, is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs with an emphasis on indications in virology and immunology. Enanta's clinical programs are currently focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting key drivers of the type 2 immune response, including KIT and STAT6 inhibition. Glecaprevir, a protease inhibitor discovered by Enanta, is part of one of the leading treatment regimens for curing acute and chronic hepatitis C virus (HCV) infection and is sold by AbbVie in numerous countries under the tradenames MAVYRET® (U.S.) and MAVIRET® (ex-U.S.) (glecaprevir/pibrentasvir). A portion of Enanta's royalties from HCV products developed under its collaboration with AbbVie contribute ongoing funding to Enanta's operations. Please visit for more information. View source version on Contacts Media and Investors Contact: Jennifer Viera617-744-3848jviera@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
33 minutes ago
- Bloomberg
MAHA Misses the Real Threats Facing the Next Generation
A new study in JAMA uses extensive data to paint a comprehensive picture of how America's children are faring — and the image is bleak. Between 2007 and 2023, their physical and mental health worsened, and chronic conditions became more common. But the most breathtaking statistic? Children in the US were 80% more likely to die than those born in other similarly wealthy countries. Whether it's death rates, chronic disease, mental health or any of the 170 measures captured in the study, the overall message is a crisis in children's health, says its lead author, Christopher Forrest, a pediatrician and health outcomes researcher at Children's Hospital of Philadelphia.
Medscape
33 minutes ago
- Medscape
Obesity-Related Cancer Deaths More Than Triple
Cancer deaths related to obesity have risen sharply over the past two decades, especially among older adults, women, non-Hispanic Black individuals and people living with obesity in rural areas, a US study found. 'Obesity is a well-known risk factor for various cancers, but its contribution to cancer-specific mortality over time hasn't been systematically quantified at a national level,' lead investigator Faizan Ahmed, MD, with Jersey Shore University Medical Center, Neptune City, New Jersey, told Medscape Medical News. 'Clinicians should recognize obesity not just as a cardiovascular or metabolic risk factor but as a significant oncologic concern,' Ahmed said. He presented his research on July 13 at ENDO 2025, The Endocrine Society Annual Meeting in San Francisco. Higher Risk for 13 Cancers According to the CDC, 40% of adults are living with obesity. Obesity is associated with a higher risk for 13 cancers, which make up 40% of all cancers diagnosed in the US each year. They are adenocarcinoma of the esophagus, postmenopausal breast cancer, as well as cancer of the colon and rectum, uterus, gallbladder, upper stomach, kidneys, liver, ovaries, pancreas, thyroid, meningioma, and multiple myeloma. To see the trends in obesity-associated cancer deaths over the past two decades, Ahmed and colleagues analyzed CDC data for 33,572 obesity and cancer-related deaths. They found that the overall age-adjusted mortality rate gradually increased from 3.73 per million in 1999 to 13.52 per million in 2020. 'That's more than a tripling in obesity-related cancer mortality rates over 20 years — a striking rise,' Ahmed told Medscape Medical News . 'To put it in context, this is a steeper increase than seen in many other chronic disease mortality trends during the same time period. It signals a rapidly escalating public health burden,' he noted. Overall, the average percent change from 2018-2020 was +19.4%. The average annual percentage change was also statistically significant at 5.92 ( P < .000001). In stratified analyses, the overall age-adjusted mortality rate per million was greater in women than in men (7.22 vs 6.59), in non-Hispanic Black persons than in non-Hispanic White persons (9.20 vs 7.13), and in adults aged 65+ than those aged 25-64 (20.82 vs 3.54). Age-adjusted mortality rates from obesity-associated cancers were also higher in rural than in urban areas (9.45 vs 6.40). By region, overall, the Midwest had the highest rates and the Northeast had the lowest rates. State-level analysis revealed that Vermont, Minnesota, and Oklahoma had the highest rates, while Utah, Alabama, and Virginia had the lowest. Underappreciated Link The link between obesity and cancer-related mortality is 'often underappreciated,' Ahmed told Medscape Medical News . 'Our findings emphasize the need to prioritize obesity screening and management as part of comprehensive cancer prevention. Counseling patients on weight management should be reframed as a critical component of reducing long-term cancer risk,' he said. Ahmed also noted that socioeconomic factors could be driving the increase in obesity-related cancer deaths. 'While BMI is a contributing factor, disparities in socioeconomic status, access to preventive care, delays in diagnosis, environmental exposures, and cultural factors likely play a larger role in the observed variations across gender and race.' 'For instance, women may face more delayed diagnoses due to under prioritized symptoms, and certain minority groups may encounter systemic barriers to cancer screening and obesity treatment,' Ahmed said. To tackle the problem of rising rates of obesity-related cancer deaths, Ahmed said policy initiatives should move from downstream management to upstream prevention. This would include 'universal access to cancer screening programs, regardless of income or geography; public health campaigns that normalize obesity management as a cancer prevention strategy; policies promoting equitable access to healthy foods, physical activity, and early intervention services; incentives for primary care to integrate weight management into routine visits; and investment in community-based care models targeting underserved populations,' Ahmed told Medscape Medical News .
